[ad_1] Lupin secures USFDA nod for biosimilar Armlupeg We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Novo Nordisk seeks USFDA approval for higher dose of Wegovy injection We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] FDA Grants Accelerated Approval to Sibeprenlimab for IgA Nephropathy We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Zydus scores tentative USFDA nod for Empagliflozin, Linagliptin Tablets for diabetes We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Biocon Biologics Bengaluru facility classified as VAI by USFDA We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Drugmaker Glenmark Pharmaceuticals Ltd on Thursday said it has received establishment inspection report from the US health regulator for its formulations manufacturing facility at Monroe, North Carolina, classifying the facility as voluntary action indicated. The inspection was conducted at the company’s manufacturing facility from June 9 to June 17, 2025, Glenmark Pharmaceuticals Ltd said…
[ad_1] Biocon Biologics, global subsidiary of Biocon Limited, informed on Thursday that the USFDA has classified its Drug Substance Facility in Bengaluru as Voluntary Action Indicated (VAI). “The U.S. Food and Drug Administration (FDA) CDER-OC, Office of Manufacturing Quality, has classified Biocon Biologics’ Drug Substance Facility at Biocon Campus, located in Bengaluru, Karnataka, as Voluntary…
[ad_1] Zydus Lifesciences bags USFDA nod for high BP tablet We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] AiMeD Hails CDSCO Medical Device Licensing Mandate but Flags Loophole for Foreign Certifications We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Indian Licensing Now Mandatory for All Medical Device Procurements We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link